ramixotidine has been researched along with pentagastrin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchetti, A; Lavezzo, A; Manara, L; Manzoni, L | 1 |
| Basilisco, G; Brassinne, A; Dresse, A; Manara, L | 1 |
| Bianchetti, A; Lavezzo, A; Manara, L; Manzoni, L; Mengozzi, G; Soldani, G | 1 |
1 trial(s) available for ramixotidine and pentagastrin
| Article | Year |
|---|---|
Inhibition of pentagastrin-stimulated gastric acid secretion and plasma levels of the new histamine H2-receptor antagonist ramixotidine dihydrochloride (CM 57755) in human volunteers.
Topics: Adult; Double-Blind Method; Gastric Acid; Gastric Mucosa; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Niacinamide; Pentagastrin; Random Allocation | 1987 |
2 other study(ies) available for ramixotidine and pentagastrin
| Article | Year |
|---|---|
Inhibition of dimaprit- and pentagastrin-induced gastric acid secretion in cats by the new histamine H2 antagonist, CM 57755.
Topics: Animals; Cats; Cimetidine; Dimaprit; Gastric Acid; Histamine H2 Antagonists; Kinetics; Male; Niacinamide; Pentagastrin; Thiourea | 1986 |
Comparison of the gastric antisecretory effects of ramixotidine dihydrochloride (CM 57755), a new H2 receptor antagonist, and cimetidine in dogs.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Dogs; Gastric Acid; Gastrins; Male; Niacinamide; Pentagastrin; Receptors, Histamine H2 | 1988 |